The 6 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 14.50, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +50.10% increase from the last price of 9.66.
The current consensus among 5 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.